Faecal Microbiota transplantation affects liver DNA methylation in Non-alcoholic fatty liver disease: a multi-omics approach

References

• Ruissen MM, Mak AL, Beuers U, Tushuizen ME, Holleboom AG. Non-alcoholic fatty liver disease: a multidisciplinary approach towards a cardiometabolic liver disease. Eur J Endocrinol. 2020;183(3):R57–15. doi:10.1530/EJE-20-0065.
   PubMed Web of Science ®Google Scholar
• Younossi Z, Tacke F, Arrese M, Chander Sharma B, Mostafa I, Bugianesi E, Wai‐Sun Wong V, Yilmaz Y, George J, Fan J, et al. Global perspectives on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Hepatology. 2019;69(6):2672–2682. doi:10.1002/hep.30251.
   PubMed Web of Science ®Google Scholar
• Huang DQ, El-Serag HB, Loomba R. Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol. 2021;18(4):223–238. doi:10.1038/s41575-020-00381-6.
   PubMed Web of Science ®Google Scholar
• Younossi ZM. Non-alcoholic fatty liver disease – A global public health perspective. J Hepatol. 2019;70(3):531–544. doi:10.1016/j.jhep.2018.10.033.
   PubMed Web of Science ®Google Scholar
• Younossi ZM, Golabi P, de Avila L, Paik JM, Srishord M, Fukui N, Qiu Y, Burns L, Afendy A, Nader F, et al. The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: a systematic review and meta-analysis. J Hepatol. 2019;71(4):793–801. doi:10.1016/j.jhep.2019.06.021.
   PubMed Web of Science ®Google Scholar
• Ruissen MM, Mak AL, Beuers U, Tushuizen ME, Holleboom AG. Non-alcoholic fatty liver disease: a multidisciplinary approach towards a cardiometabolic liver disease. Eur J Endocrinol. 2020;183(3):R57–R73. doi:10.1530/EJE-20-0065.
   PubMed Web of Science ®Google Scholar
• Ekstedt M, Hagström H, Nasr P, Fredrikson M, Stål P, Kechagias S, Hultcrantz R. Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up. Hepatology. 2015;61(5):1547–1554. doi:10.1002/hep.27368.
   PubMed Web of Science ®Google Scholar
• Simon TG, Roelstraete B, Hagström H, Sundström J, Ludvigsson JF. Non-alcoholic fatty liver disease and incident major adverse cardiovascular events: results from a nationwide histology cohort. Gut. 2021;71(9):1867–1875. (Cvd):gutjnl-2021-325724. doi:10.1136/gutjnl-2021-325724.
   PubMed Web of Science ®Google Scholar
• Hanssen NMJ, de Vos WM, Nieuwdorp M. Fecal microbiota transplantation in human metabolic diseases: from a murky past to a bright future? Cell Metab. 2021;33(6):1098–1110. doi:10.1016/j.cmet.2021.05.005.
   PubMed Web of Science ®Google Scholar
• Aron-Wisnewsky J, Warmbrunn MV, Nieuwdorp M, Clément K. Nonalcoholic fatty liver disease: modulating gut microbiota to improve severity? Gastroenterology. 2020;158(7):1881–1898. doi:10.1053/j.gastro.2020.01.049.
   PubMed Web of Science ®Google Scholar
• van der Vossen EWJ, Bastos D, Stols-Gonçalves D, van der Vossen EWJ, de Goffau MC, Davids M, Pereira JPB, Li Yim AYF, Henneman P, Netea MG, et al. Effects of fecal microbiota transplant on DNA methylation in subjects with metabolic syndrome. Gut Microbes. 2021;13(1):1–18. doi:10.1080/19490976.2021.1993513.
   Web of Science ®Google Scholar
• Ling C, Rönn T. Epigenetics in human obesity and type 2 diabetes. Cell Metab. 2019;29(5):1028–1044. doi:10.1016/j.cmet.2019.03.009.
   PubMed Web of Science ®Google Scholar
• Egger G, Liang G, Aparicio A, Jones PA. Epigenetics in human disease and prospects for epigenetic therapy. Nature. 2004;429(6990):457–463. doi:10.1038/nature02625.
   PubMed Web of Science ®Google Scholar
• Ansari I, Raddatz G, Gutekunst J, Ridnik M, Cohen D, Abu-Remaileh M, Tuganbaev T, Shapiro H, Pikarsky E, Elinav E, et al. The microbiota programs DNA methylation to control intestinal homeostasis and inflammation. Nat Microbiol. 2020;5(4):610–619. doi:10.1038/s41564-019-0659-3.
   PubMed Web of Science ®Google Scholar
• Yao H, Fan C, Lu Y, Fan X, Xia L, Li P, Wang R, Tang T, Wang Y, Qi K, et al. Alteration of gut microbiota affects expression of adiponectin and resistin through modifying DNA methylation in high-fat diet-induced obese mice. Genes Nutr. 2020;15(1). doi:10.1186/s12263-020-00671-3.
   PubMed Web of Science ®Google Scholar
• Ramos-Molina B, Sánchez-Alcoholado L, Cabrera-Mulero A,Ramos-Molina B, Sánchez-Alcoholado L, Cabrera-Mulero A, Lopez-Dominguez R, Carmona-Saez P, Garcia-Fuentes E, Moreno-Indias I, Tinahones FJ. Gut microbiota composition is associated with the global DNA methylation pattern in obesity. Front Genet. 2019;10(JUL):1–9. doi:10.3389/fgene.2019.00613.
   PubMedGoogle Scholar
• Yao H, Mo S, Wang J, Li Y, Wang C-Z, Wan J-Y, Zhang Z, Chen Y, Sun R, Yuan C-S, et al. Genome-wide DNA methylation profiles of phlegm-dampness constitution. Cell Physiol Biochem. 2018;45(5):1999–2008. doi:10.1159/000487976.
   PubMedGoogle Scholar
• Guo W, Zhang Z, Li L, Liang X, Wu Y, Wang X, Ma H, Cheng J, Zhang A, Tang P, et al. Gut microbiota induces DNA methylation via SCFAs predisposing obesity-prone individuals to diabetes. Pharmacol Res. 2022;182(11):106355. doi:10.1016/j.phrs.2022.106355.
   PubMedGoogle Scholar
• Stols-Gonçalves D, Tristão LS, Henneman P, Nieuwdorp M. Epigenetic markers and microbiota/metabolite-induced epigenetic modifications in the pathogenesis of obesity, metabolic syndrome, type 2 diabetes, and non-alcoholic fatty liver disease. Curr Diab Rep. 2019;19(6):1–9. doi:10.1007/s11892-019-1151-4.
   PubMed Web of Science ®Google Scholar
• Hyun J, Jung Y. Dna methylation in nonalcoholic fatty liver disease. Int J Mol Sci. 2020;21(21):1–26. doi:10.3390/ijms21218138.
   Web of Science ®Google Scholar
• Pirola CJ, Scian R, Gianotti TF, Dopazo H, Rohr C, Martino JS, Castaño GO, Sookoian S. Epigenetic modifications in the biology of nonalcoholic fatty liver disease: the role of DNA hydroxymethylation and TET proteins. Med (United States). 2015;94(36):1–10. doi:10.1097/MD.0000000000001480.
   Google Scholar
• Kim H, Worsley O, Yang E, Purbojati RW, Liang AL, Tan W, Moses DID, Hartono S, Fan V, Lim TKH, et al. Persistent changes in liver methylation and microbiome composition following reversal of diet-induced non-alcoholic-fatty liver disease. Cell Mol Life Sci. 2019;76(21):4341–4354. doi:10.1007/s00018-019-03114-4.
   PubMed Web of Science ®Google Scholar
• Witjes JJ, Smits LP, Pekmez CT, Prodan A, Meijnikman AS, Troelstra MA, Bouter KEC, Herrema H, Levin E, Holleboom AG, et al. Donor fecal microbiota transplantation alters gut microbiota and metabolites in obese individuals with steatohepatitis. Hepatol Commun. 2020;4(11):1578–1590. doi:10.1002/hep4.1601.
   PubMed Web of Science ®Google Scholar
• Rauschert S, Raubenheimer K, Melton PE, Huang RC. Machine learning and clinical epigenetics: a review of challenges for diagnosis and classification. Clin Epigenetics. 2020;12(1). doi:10.1186/s13148-020-00842-4.
   PubMed Web of Science ®Google Scholar
• Jiao N, Loomba R, Yang ZH, Wu D, Fang S, Bettencourt R, Lan P, Zhu R, Zhu L. Alterations in bile acid metabolizing gut microbiota and specific bile acid genes as a precision medicine to subclassify nafld. Physiol Genomics. 2021;53(8):336–348. doi:10.1152/physiolgenomics.00011.2021.
   PubMed Web of Science ®Google Scholar
• Newman TM, Shively CA, Register TC, Appt SE, Yadav H, Colwell RR, Fanelli B, Dadlani M, Graubics K, Nguyen UT, et al. Diet, obesity, and the gut microbiome as determinants modulating metabolic outcomes in a non-human primate model. Microbiome. 2021;9(1):1–17. doi:10.1186/s40168-021-01069-y.
   PubMed Web of Science ®Google Scholar
• Liu X, Mao B, Gu J, Wu J, Cui S, Wang G, Zhao J, Zhang H, Chen W. Blautia—a new functional genus with potential probiotic properties? Gut Microbes. 2021;13(1):1–21. doi:10.1080/19490976.2021.1875796.
   Web of Science ®Google Scholar
• Benítez-Páez A, Gómez Del Pugar EM, López-Almela I, Moya-Pérez Á, Codoñer-Franch P, Sanz Y, Turnbaugh PJ. Depletion of Blautia species in the microbiota of obese children relates to intestinal inflammation and metabolic phenotype worsening. mSystems. 2020;5(2):1–13. doi:10.1128/msystems.00857-19.
   Web of Science ®Google Scholar
• Pataky Z, Genton L, Spahr L, Lazarevic V, Terraz S, Gaïa N, Rubbia-Brandt L, Golay A, Schrenzel J, Pichard C, et al. Impact of hypocaloric hyperproteic diet on gut microbiota in overweight or obese patients with nonalcoholic fatty liver disease: a pilot study. Dig Dis Sci. 2016;61(9):2721–2731. doi:10.1007/s10620-016-4179-1.
   PubMed Web of Science ®Google Scholar
• Hosomi K, Saito M, Park J, Murakami H, Shibata N, Ando M, Nagatake T, Konishi K, Ohno H, Tanisawa K, et al. Oral administration of Blautia wexlerae ameliorates obesity and type 2 diabetes via metabolic remodeling of the gut microbiota. Nat Commun. 2022;13(1):1–17. doi:10.1038/s41467-022-32015-7.
   PubMed Web of Science ®Google Scholar
• Yang D, Brunengraber H. Glutamate, a window on liver intermediary metabolism. J Nutr. 2000;130(4):991–994. doi:10.1093/jn/130.4.991s.
   Web of Science ®Google Scholar
• Lefebvre R. Impact of phenylacetic acid, a microbiota-derived metabolite, on hepatic endoplasmic reticulum-mitochondria interactions and steatosis. 2022. https://www.abstractsonline.com/pp8/#!/10613/presentation/1413.
   Google Scholar
• Nemet I, Saha PP, Gupta N, Zhu W, Romano KA, Skye SM, Cajka T, Mohan ML, Li L, Wu Y, et al. A cardiovascular disease-linked gut microbial metabolite acts via adrenergic receptors. Cell. 2020;180(5):862–877.e22. doi:10.1016/j.cell.2020.02.016.
   PubMed Web of Science ®Google Scholar
• Hoyles L, Fernández-Real JM, Federici M, Serino M, Abbott J, Charpentier J, Heymes C, Luque JL, Anthony E, Barton RH, et al. Molecular phenomics and metagenomics of hepatic steatosis in non-diabetic obese women. Nat Med. 2018;24(7):1070–1080. doi:10.1038/s41591-018-0061-3.
   PubMed Web of Science ®Google Scholar
• Oh KK, Gupta H, Min BH, Ganesan R, Sharma SP, Won SM, Jeong JJ, Lee SB, Cha MG, Kwon GH, et al. The identification of metabolites from gut microbiota in NAFLD via network pharmacology. Sci Rep. 2023;13(1):1–13. doi:10.1038/s41598-023-27885-w.
   PubMed Web of Science ®Google Scholar
• Perng W, Rahman ML, Aris IM, Michelotti G, Sordillo JE, Chavarro JE, Oken E, Hivert M-F. Metabolite profiles of the relationship between body mass index (BMI) milestones and metabolic risk during early adolescence. Metabolites. 2020;10(8):1–23. doi:10.3390/metabo10080316.
   Web of Science ®Google Scholar
• Madiraju P, Pande SV, Prentki M, Madiraju SRM. Mitochondrial acetylcarnitine provides acetyl groups for nuclear histone acetylation. Epigenetics. 2009;4(6):399–403. doi:10.4161/epi.4.6.9767.
   PubMed Web of Science ®Google Scholar
• Smallwood T, Allayee H, Bennett BJ. Choline metabolites: gene by diet interactions. Curr Opin Lipidol. 2016;27(1):33–39. doi:10.1097/MOL.0000000000000259.
   PubMed Web of Science ®Google Scholar
• Steven HZ. Gene response elements, genetic polymorphisms and epigenetics influence the human dietary requirement for choline. IIUBMB Life. 2007;59(6):380–387. doi:10.1080/15216540701468954.
   PubMed Web of Science ®Google Scholar
• Stetten, Jr DW, Salcedo, Jr J. The effect of chain length of the dietary fatty acid upon the fatty liver of choline deficiency. J Nutr. 1945;29(3):167–170. doi:10.1093/jn/29.3.167.
   Google Scholar
• Spencer MD, Hamp TJ, Reid RW, Fischer LM, Steven H, Fodor AA. Association between composition of the human gastrointestinal microbiome and development of fatty liver with choline deficiency Melanieelanie. Gastroenterology. 2012;140(3):976–986. doi:10.1053/j.gastro.2010.11.049.
   Web of Science ®Google Scholar
• Dumas ME, Barton RH, Toye A, Cloarec O, Blancher C, Rothwell A, Fearnside J, Tatoud R, Blanc V, Lindon JC, et al. Metabolic profiling reveals a contribution of gut microbiota to fatty liver phenotype in insulin-resistant mice. Proc Natl Acad Sci USA. 2006;103(33):12511–12516. doi:10.1073/pnas.0601056103.
   PubMed Web of Science ®Google Scholar
• Kinchen JM, Mohney RP, Pappan KL. Long-chain acylcholines link butyrylcholinesterase to regulation of non-neuronal cholinergic signaling. J Proteome Res. 2022;21(3):599–611. doi:10.1021/acs.jproteome.1c00538.
   PubMed Web of Science ®Google Scholar
• Romano KA, Vivas EI, Amador-Noguez D, Rey FE, Blaser MJ. Intestinal microbiota composition modulates choline bioavailability from diet and accumulation of the proatherogenic metabolite trimethylamine-N-oxide. MBio. 2015;6(2):1–8. doi:10.1128/mBio.02481-14.
   Web of Science ®Google Scholar
• Samuel VT, Shulman GI. Nonalcoholic fatty liver disease as a nexus of metabolic and hepatic diseases. Cell Metab. 2018;27(1):22–41. doi:10.1016/j.cmet.2017.08.002.
   PubMed Web of Science ®Google Scholar
• Grefhorst A, van de Peppel IP, Larsen LE, Jonker JW, Holleboom AG, van de Peppel IP. The role of lipophagy in the development and treatment of non-alcoholic fatty liver disease. Front Endocrinol. 2021;11(February):1–12. doi:10.3389/fendo.2020.601627.
   Google Scholar
• Theil AF, Botta E, Raams A, Smith DEC, Mendes MI, Caligiuri G, Giachetti S, Bione S, Carriero R, Liberi G, et al. Bi-allelic TARS mutations are associated with brittle hair phenotype. Am J Hum Genet. 2019;105(2):434–440. doi:10.1016/j.ajhg.2019.06.017.
   PubMed Web of Science ®Google Scholar
• TARS 1 Genecards. https://www.genecards.org/cgi-bin/carddisp.pl?gene=TARS1#expression.
   Google Scholar
• Wang H, Liu Y, Wang D, Xu Y, Dong R, Yang Y, Lv Q, Chen X, Zhang Z. The upstream pathway of mtor-mediated autophagy in liver diseases. Cells. 2019;8(12):1597. doi:10.3390/cells8121597.
   PubMed Web of Science ®Google Scholar
• Monteagudo-Sánchez A, Hernandez Mora JR, Simon C, Burton A, Tenorio J, Lapunzina P, Clark S, Esteller M, Kelsey G, López-Siguero JP, et al. The role of ZFP57 and additional KRAB-zinc finger proteins in the maintenance of human imprinted methylation and multi-locus imprinting disturbances. Nucleic Acids Res. 2020;48(20):11394–11407. doi:10.1093/nar/gkaa837.
   PubMed Web of Science ®Google Scholar
• Mackay DJG, Callaway JLA, Marks SM, White HE, Acerini CL, Boonen SE, Dayanikli P, Firth HV, Goodship JA, Haemers AP, et al. Hypomethylation of multiple imprinted loci in individuals with transient neonatal diabetes is associated with mutations in ZFP57. Nat Genet. 2008;40(8):949–951. doi:10.1038/ng.187.
   PubMed Web of Science ®Google Scholar
• Héberlé É, Bardet AF, Blewitt M. Sensitivity of transcription factors to DNA methylation. Essays Biochem. 2019;63(6):727–741. doi:10.1042/EBC20190033.
   PubMed Web of Science ®Google Scholar
• Rinella ME, Tacke F, Sanyal AJ, Anstee QM. Report on the AASLD/EASL joint workshop on clinical trial endpoints in NAFLD. J Hepatol. 2019;71(4):823–833. doi:10.1016/j.jhep.2019.04.019.
   PubMed Web of Science ®Google Scholar
• Chen S, Zhou Y, Chen Y, Gu J. Fastp: an ultra-fast all-in-one FASTQ preprocessor. Bioinformatics. 2018;34(17):i884–i890. doi:10.1093/bioinformatics/bty560.
   PubMed Web of Science ®Google Scholar
• Langmead B, Salzberg SL. Fast gapped-read alignment with Bowtie 2. Nat Methods. 2012;9(4):357–359. doi:10.1038/nmeth.1923.
   PubMed Web of Science ®Google Scholar
• Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N, Marth G, Abecasis G, Durbin R. The sequence alignment/map format and SAMtools. Bioinformatics. 2009;25(16):2078–2079. doi:10.1093/bioinformatics/btp352.
   PubMed Web of Science ®Google Scholar
• Tarasov A, Vilella AJ, Cuppen E, Nijman IJ, Prins PS. Sambamba: fast processing of NGS alignment formats. Bioinformatics. 2015;31(12):2032–2034. doi:10.1093/bioinformatics/btv098.
   PubMed Web of Science ®Google Scholar
• Quinlan AR, Hall IM. Bedtools: a flexible suite of utilities for comparing genomic features. Bioinformatics. 2010;26(6):841–842. doi:10.1093/bioinformatics/btq033.
   PubMed Web of Science ®Google Scholar
• Beghini F, McIver LJ, Blanco-Míguez A, Dubois L, Asnicar F, Maharjan S, Mailyan A, Manghi P, Scholz M, Thomas AM, et al. Integrating taxonomic, functional, and strain-level profiling of diverse microbial communities with biobakery 3. Elife. 2021;10:1–42. doi:10.7554/eLife.65088.
   Web of Science ®Google Scholar
• Buchfink B, Xie C, Huson DH. Fast and sensitive protein alignment using DIAMOND. Nat Methods. 2014;12(1):59–60. doi:10.1038/nmeth.3176.
   PubMed Web of Science ®Google Scholar
• Koh A, Molinaro A, Ståhlman M, Khan MT, Schmidt C, Mannerås-Holm L, Wu H, Carreras A, Jeong H, Olofsson LE, et al. Microbially produced imidazole propionate impairs insulin signaling through mTORC1. Cell. 2018;175(4):947–961.e17. doi:10.1016/j.cell.2018.09.055.
   PubMed Web of Science ®Google Scholar
• Fortin J-P, Fertig E, Hansen K. shinyMethyl: interactive quality control of Illumina 450k DNA methylation arrays in R. F1000Research. 2014 May;3:1–10. doi:10.12688/f1000research.4680.1.
   PubMedGoogle Scholar
• Aryee MJ, Jaffe AE, Corrada-Bravo H, Ladd-Acosta C, Feinberg AP, Hansen KD, Irizarry RA. Minfi: a flexible and comprehensive Bioconductor package for the analysis of Infinium DNA methylation microarrays. Bioinformatics. 2014;30(10):1363–1369. doi:10.1093/bioinformatics/btu049.
   PubMed Web of Science ®Google Scholar
• Zhou W, Laird PW, Shen H. Comprehensive characterization, annotation and innovative use of Infinium DNA methylation BeadChip probes. Nucleic Acids Res. 2017;45(4):e22. doi:10.1093/nar/gkw967.
   PubMed Web of Science ®Google Scholar
• Andrews SV, Ladd-Acosta C, Feinberg AP, Hansen KD, Fallin MD. “Gap hunting” to characterize clustered probe signals in Illumina methylation array data. Epigenetics Chromatin. 2016;9(1):1–21. doi:10.1186/s13072-016-0107-z.
   PubMedGoogle Scholar
• Geurts P, Ernst D, Wehenkel L. Extremely randomized trees. Mach Learn. 2006;63(1):3–42. doi:10.1007/s10994-006-6226-1.
   Web of Science ®Google Scholar
• Meinshausen N, Bühlmann P. Stability selection. J R Stat Soc Ser B Stat Methodol. 2010;72(4):417–473. doi:10.1111/j.1467-9868.2010.00740.x.
   Google Scholar
• Pedregosa F, Duchesnay É. Scikit-learn: machine learning in python. J Mach Learn Res. 2011;12:2825–2830.
   Web of Science ®Google Scholar